JanOne Inc

NASDAQ:JAN  
5.18
+0.11 (+2.17%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

JanOne Inc Stock, NASDAQ:JAN

325 East Warm Springs Road, Suite 102, Las Vegas, Nevada 89119-4238
United States of America
Phone: +1.702.997.5968
Number of Employees: 179

Description

JanOne, Inc. focuses on developing treatments for diseases that cause severe pain. It aims to reduce the need for opioid prescriptions to treat disease associated pain that can lead to opioid abuse. The firm also provides solutions for non-addictive pain medications. Its lead candidate JAN101 is for treating peripheral artery disease (PAD), a condition that affects over 8.5 million Americans. JanOne is dedicated to funding resources toward innovation, technology, and education for PAD, associated vascular conditions and neuropathic pain. The company continues to operate its legacy businesses under their current brand names, which are undergoing review to determine appropriate strategic alternatives. JanOne was founded by Edward R. Cameron in 1976 and is headquartered in Las Vegas, NV.